Heterogeneous Data Integration to Infer SARS-CoV-2 Variant-Specific Immunity for Risk Assessment and Vaccine Design
Max von Kleist, Claudia Schillings, René Henrion
01.01.2024 – 31.12.2025
COVID-19 remains a dangerous pandemic. Nowadays, the spread and evolution of the virus is driven by immune dynamics and the ability of infection-induced immune response to cross-neutralize circulating variants. We will enable SARS-CoV-2 data
integration across multiple spatial scales to estimate variant-specific population immunity from infection history; to inform variant risk assessment and the selection of vaccine candidates.